US 10981896
Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase
granted A61KA61K31/496A61K45/06
Quick answer
US patent 10981896 (Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase) held by The Board of Regents of the University of Texas System expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/496, A61K45/06